Position in RVMD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,458,750
+$1,008,993 QoQ
Shares Held
15,000
+22.7% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RVMD Over Time
Shares Held
Position Value (USD)
Derivatives in RVMD
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$1,458,750
PutShares
15,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Diametric Capital, LP holds $50,198,214 across 62 Biotechnology names. RVMD ranks #5 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PGEN |
Precigen, Inc.
|
6,801,788 | $26,322,919 | |
| 2 | ABEO |
Abeona Therapeutics Inc.
|
611,520 | $2,739,609 | |
| 3 | VKTX |
Viking Therapeutics, Inc.
|
63,896 | $2,079,175 | |
| 4 | SLNO |
Soleno Therapeutics Inc
|
57,832 | $1,936,215 | |
| 5 | RVMD |
Revolution Medicines, Inc.
This page
|
15,000 | $1,458,750 | |
| 6 | ENLV |
Enlivex Ltd.
|
1,483,178 | $1,379,355 | |
| 7 | ABVX |
Abivax S.A.
|
10,000 | $1,113,500 | |
| 8 | OCUL |
Ocular Therapeutix, Inc
|
125,000 | $1,058,750 |
All Filings in RVMD
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,458,750 | 15,000 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $1,458,750 | 15,000 | Shares | Defined | 2026-05-15 | |
| 2025-06-30 | $449,757 | 12,225 | Shares | Defined | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||